LinkedIn: Maria Jure-Kunkel | LinkedIn
Maria Jure-Kunkel. Immuno-Oncology Translational Medicine. Lokalizacja Obszar metropolitalny Nowy Jork, Stany Zjednoczone Branża Farmacja
LinkedIn: Maria Jure-Kunkel | LinkedIn
Maria Jure-Kunkels berufliches Profil anzeigen LinkedIn ist das weltweit größte professionelle Netzwerk, das Fach- und Führungskräften wie Maria Jure-Kunkel …
LinkedIn: Maria Jure-Kunkel | LinkedIn
View Maria Jure-Kunkel’s professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Maria Jure-Kunkel discover ...
Maria Jure-Kunkel - Patents
www.freshpatents.com
Recent bibliographic sampling of Maria Jure-Kunkel patents listed/published in the public domain by the USPTO (USPTO Patent Application #,Title):
Maria Jure-Kunkel | XanEdu Customization Platform
www.academicpub.com
Author: Maria Jure-Kunkel. Results. Treatment with anti-CD137 mAbs causes intense accumulations of liver T cells without selective antitumor ...
Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell...
www.urotoday.com
· ... Tina C Young, Scott D Chasalow, Petra Ross-MacDonald, Shivani Srivastava, Maria Jure-Kunkel, John F Kurland, Jason S Simon, Mario Sznol ...
Immune Checkpoint Inhibitors in RCC: How Can We Get More
www.niu.edu
Howard Scher. • Eugene Kwon. • Patients and Families. BMS. • Alan Korman. • Mark Selby. • Kent Thudium. • Nils Lonberg. • Maria Jure-Kunkel.
OASIS
www.abstractsonline.com
... Kurt A. Schalper1, Guillermo Mazzolini3, Francesca Sarno4, Manuel Hidalgo4, Alan J. Korman5, Maria Jure-Kunkel6, Ignacio Melero2. 1Yale ...
Internal Server Error
www.sciencedirect.com
Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain. ,. Maria Jure-Kunkel. x. Maria Jure-Kunkel. Search for articles by ...
Hypoxia-induced soluble CD137 in malignant cells blocks...
jitc.biomedcentral.com
... Aizea Morales-Kastresana, Elena Marin, Alfonso Gurpide, Maria Rodriguez-Ruiz, M Angela Aznar, Maria Jure-Kunkel and Ignacio Melero.
Publications Authored by Maria Jure-Kunkel | PubFacts
www.pubfacts.com
Publications by authors named "Maria Jure-Kunkel" Are you Maria Jure-Kunkel? Register this Author. 38Publications Reads. 15Profile Views. Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells. Authors:
Maria Jure-Kunkel's Research | CureHunter
www.curehunter.com
Maria Jure-Kunkel Selected Research Maria Jure-Kunkel Research Topics. Disease. 12: Neoplasms (Cancer) : 4: Melanoma (Melanoma ...
All web results to the name "Maria Jure"
Maria Jure-Kunkel | LinkedIn
www.linkedin.com
View Maria Jure-Kunkel's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Maria Jure-Kunkel ...
Maria Jure-Kunkel | LinkedIn
www.linkedin.com
Director Translational Research at Bristol-Myers Squibb Join LinkedIn and access Maria’s full profile Successful collaborator with robust partnerships with well recognized external Oncology/Immuno-Oncology scientifists.Recipient of several patents, co-author of numerous ...
Maria Jure-Kunkel, Plainsboro US - Patent applications
www.patentsencyclopedia.com
Patent application number, Description, Published , Fully human antibodies against human 4-1BB - Fully human antibodies and antigen-binding ...
Immunomodulatory activity of nivolumab in metastatic renal cell...
jhu.pure.elsevier.com
... Scott D. Chasalow, Petra Ross-Macdonald, Shivani Srivastava & 4 others Maria Jure-Kunkel, John F. Kurland, Jason S. Simon, Mario Sznol.
Related search requests for Maria Jure
| Mario Sznol |
Person "Jure" (1) Forename "Maria" (118695) Name "Jure" (78) |
sorted by relevance / date